CC
AMED

Curian Capital’s Amedisys AMED Stock Holding History

Curian Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,078
Closed -$162K – 589
2013
Q4 		$162K Buy
11,078
+164
+2% +$2.64K ﹤0.01% 543
2013
Q3 		$188K Buy
10,914
+133
+1% +$1.97K ﹤0.01% 559
2013
Q2 		$125K Buy
+10,781
New +$123K ﹤0.01% 558

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Curian Capital's AMED Position: Q1 2014 in Review

Curian Capital sold out of Amedisys (AMED) in Q1 2014, closing a stake of 11,078 shares — an estimated $162K sold.

Curian Capital first reported a position in AMED in Q2 2013 and held it in 3 quarters. The position peaked at $188K in Q3 2013. 120 funds tracked by Wall St. Rank hold AMED as of Q1 2014.

  • Curian Capital reported no remaining Amedisys position as of Q1 2014 after selling out during the quarter.
  • Curian Capital sold 11,078 Amedisys shares in Q1 2014, an estimated $162K.
  • Curian Capital first reported a position in Amedisys in Q2 2013 and held it in 3 quarters.
  • Curian Capital's Amedisys position peaked at $188K in Q3 2013.
  • 120 funds tracked by Wall St. Rank held Amedisys as of Q1 2014.

Based on Curian Capital's 13F filing for Q1 2014, filed 12 May 2014.